Article
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma…
medRxiv · 2023 · Ann-Kathrin Daum
Key facts
| Title | Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis |
|---|---|
| First author | Ann-Kathrin Daum |
| Journal | medRxiv |
| Published | Aug 11, 2023 |
| DOI | 10.1101/2023.08.08.552439 |
| Devices mentioned | K800552, K810863, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 11 more |
| Product codes mentioned | DBM, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1